版本:
中国

BRIEF-Flex Pharma says US Phase 2 trial of FLX-787 in CMT patients to start this summer

June 2 Flex Pharma Inc

* Flex Pharma’S Phase 2 trial with FLX-787 in charcot-marie-tooth endorsed by the inherited neuropathies consortium

* Flex Pharma Inc says US Phase 2 trial of FLX-787 in CMT patients to start this summer Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐